

The provided vulnerability data refers to CVE-2023-6260, which affects Brivo ACS100 and ACS300 products. The vulnerability is classified as "Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection')" and can be exploited remotely. The vulnerability has a CVSS score of 9.0, indicating a critical severity, and can lead to bypassing physical security, allowing an attacker to execute arbitrary commands on the system.

The vulnerability is caused by improper neutralization of special elements used in an OS command, which can be exploited by an attacker to inject malicious commands. The attack vector is adjacent network, and the attack complexity is low, requiring only a single request to exploit. The vulnerability can be exploited by a low-privileged attacker, and there is no user interaction required.

The vulnerability has been identified in Brivo ACS100 (Network Adjacent Access) and ACS300 (Physical Access) versions 5.2.4 and earlier, and has been fixed in version 6.2.4.3. The vulnerability has been discovered by sra.io and has been assigned the identifier 57dba5dd-1a03-47f6-8b36-e84e47d335d8.

The vulnerability is also associated with the CWE-78 weakness, which refers to the use of dangerous functions or APIs. The vulnerability has been referenced in the sra.io advisory, which provides additional information on the vulnerability and its exploitation.

In summary, CVE-2023-6260 is a critical vulnerability in Brivo ACS100 and ACS300 products that can be exploited remotely to bypass physical security and execute arbitrary commands on the system. The vulnerability has been identified and fixed by the vendor, and users are advised to update their systems to the latest version to mitigate the risk.